Drug · CHEMBL3
Comparisons in its trials380
Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.
1 to 20 of 380
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Proactive Group vs Reactive Group: serious adverse events | 16 of 649 | 6 of 649 | 1,298 | NCT00632411 | Trial comparisons |
| Nicotine vs Placebo: serious adverse events | 20 of 597 | 14 of 601 | 1,198 | NCT02355665 | Trial comparisons |
| Proactive Group vs Reactive Group: Continuous Abstinence | 173 of 521 | 136 of 529 | 1,050 | NCT00632411 | Trial comparisons |
| Opt Out vs Opt In: deaths from any cause | 27 of 655 | 19 of 345 | 1,000 | NCT02721082 | Trial comparisons |
| Opt Out vs Opt In: serious adverse events | 191 of 655 | 89 of 345 | 1,000 | NCT02721082 | Trial comparisons |
| Intervention vs Control: Number of Participants With Self-reported Tobacco Abstinence in Past 7 Days | 95 of 482 | 79 of 352 | 834 | NCT03717051 | Trial comparisons |
| Intervention vs Control: Number of Participants With Self-reported Use of NRT in Past Week/Month | 92 of 482 | 86 of 352 | 834 | NCT03717051 | Trial comparisons |
| Intervention vs Control: Number of Participants With Self-reported Quit Attempt | 214 of 482 | 153 of 352 | 834 | NCT03717051 | Trial comparisons |
| Intervention vs Control: Number of Participants With Self-reported Tobacco Abstinence in Past 7 Days | 104 of 482 | 92 of 352 | 834 | NCT03717051 | Trial comparisons |
| Intervention vs Control: Number of Participants Who Enroll in Any Smoking Cessation Service in Hong Kong | 156 of 482 | 158 of 352 | 834 | NCT03717051 | Trial comparisons |
| Intervention vs Control: Number of Participants With Self-reported Quit Attempt | 300 of 482 | 243 of 352 | 834 | NCT03717051 | Trial comparisons |
| Intervention vs Control: Number of Participants Who Enroll in Any Smoking Cessation Service in Hong Kong | 247 of 482 | 213 of 352 | 834 | NCT03717051 | Trial comparisons |
| Intervention vs Control: Biochemically Validated Abstinence at 6-month Follow-up | 22 of 482 | 10 of 352 | 834 | NCT03717051 | Trial comparisons |
| Intervention vs Control: Number of Participants With Self-reported Tobacco Abstinence in Past 30 Days | 68 of 482 | 52 of 352 | 834 | NCT03717051 | Trial comparisons |
| Intervention vs Control: Number of Participants With Self-reported Tobacco Abstinence in Past 30 Days | 93 of 482 | 77 of 352 | 834 | NCT03717051 | Trial comparisons |
| Intervention vs Control: Number of Participants With Self-reported Use of NRT in Past Week/Month | 192 of 482 | 121 of 352 | 834 | NCT03717051 | Trial comparisons |
| Intervention vs Control: deaths from any cause | 0 of 482 | 0 of 352 | 834 | NCT03717051 | Trial comparisons |
| Intervention vs Control: serious adverse events | 0 of 482 | 0 of 352 | 834 | NCT03717051 | Trial comparisons |
| Nicotine Patch, Experimental Use vs Nicotine Patch, Labeled Use: Adverse Drug Effects | 37 of 356 | 27 of 345 | 701 | NCT01807871 | Trial comparisons |
| Nicotine Patch, Experimental Use vs Nicotine Patch, Labeled Use: deaths from any cause | 1 of 356 | 1 of 345 | 701 | NCT01807871 | Trial comparisons |
pipelines-2026-09-18-0.3.1
Sources 7
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ConductCognition's list of its testsOur own data
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/drugs/v1/CHEMBL3/comparisons